Keratosis lichenoides chronica Case report KERATOSIS LICHENOIDES CHRONICA A. Smrkolj*, R. Popovič and T. Lunder ABSTRACT Keratosis lichenoides chronica is a chronic dermatosis, generally of benign nature, yet refractory to treatment. Our 54-year-old man patient, who is the 40th case reported in the literature, presented with a 15- year history of skin lesions, which were clinically, histopathologically, immunohistologically and electron microscopically compatible with keratosis lichenoides chronica. As a child he was taking antimalarial drugs and later on he was treated with antituberculous drugs. For the past 18 years he has presented with signs of periodic allergic rhinitis. The Re-PUVA therapy produced some improvement in some areas, keratotic papules with keratotic plugs had disappeared and the papules flattened. The results were superior to those obtained by local selective phototherapy or by systemic treatment with etretinate (Tigason). The patient was therapeutically unresponsive to topical application of steroids, 0,5% tretinoin and tar preparations. Systematically administered therapy had only a temporary effect on the dermal lymphocytic and histiocytic infiltrate. Considering the pathogenesis of keratosis lichenoides chronica and the composition of the dermal infiltrate, we think it reasonable to try cyclosporin A but our patient refused it. KEY WORDS keratosis lichenoides chronica, histopathology, ultrastmcture, treatment INTRODUCTION Since 1886, when Kaposi first described keratosis lichenoides chronica (KLC) until 1991, 38 cases of KLC had been described (1). In 1992, a new case of KLC was reported (2). As it is still unclear whether the dermatosis is an independent disease entity, or solely a variant of lichen ruber planus, it has been described under a wide variety of names, such as lichen ruber moniliformis (Kaposi 1886), lichen ruber acuminatus verrucosus et reticularis (Kaposi 1895), porokeratosis striata (Nekam 1938), dermatose papulohyperkeratosique en stries (Bureau, Barriere 1970), keratose lichenoide striee (Degas 1974), lichenoid trikeratosis (Pinol-Augade 1974), and keratosis lichenoides chronica (Margolis 1972) (1). * Anica Smrkolj MD, PhD has passed away unexpectedly. A short obituary is included in this issue. acta dennatovenerologica A.P.A. Vol 4, 95, No 2 67 Keratosis lichenoides chronica The disease runs a chronic course without spontaneous remissions. It is most refractory to treatment and affects patients of both sexes and all age groups. The disease is characterized by keratotic papules and plaques, commonly involving the limbs, and by erythematosquamous foci, noticed generally on the face. Nail lesions, keratosis of the palmar and plantar skin, erosions and cellular infiltrations involving the mucous membrane of mouth, genitals, eyes, upper respiratory tract and oesophagus may be also present. There is no systemic involvement and the lesions leave no scarring. Histologically, KLC frequently resembles lichen ruber planus. In the differential diagnosis Reiter's disease, Kyrle's disease, psoriasis vulgaris, keratosis follicularis, lichen ruber verrucosus, pityriasis rubra pilaris and lupus erythematosus have to be ruled out (1-4). CASE REPORT A 58-year-old patient, bom in Macedonia, presented with a 15-year history of non-itchy skin lesions involving tbe upper and lower extremities and tbe gluteal area. Tbe lesions were slowly progredient, unresponsive to local treatment and of seasonal cbaracter. Tbe patient used to squeeze wbitisb comedo-like material from keratotic papules, wbicb tended to suppurate in tbe summer. Tbe plaquelike lesions were scaly and severely inflamed. His nails bad reportedly become tbicker and brittle during tbe past year. He gave a bistory of wbooping cougb in cbildbood. As adolescent be bad endemic malaria, wbicb was treated by antimalarial agents. At the age of 23 be developed pulmonary tuberculosis and was placed on a 9-montb course of antituberculous drugs. His bistory also revealed uretbritis of unexplained etiology, wbicb had never recurred. Since the age of 30 be bas been taking antibistamines to treat allergic rbinitis wbicb tended to occur in tbe spring due to exposure to pollens, as confirmed by tbe prick tests. Five years before present admission be was taking antacids for erosive gastritis. He also gave a bistory of pain in tbe rigbt elbow and sboulder for 2 years. Tbe patient is by profession a cellist. He denied drinking alcohol and smoking. In 1993 be was admitted to tbe hospital twice. Since 1985 be bas been treated at tbe Department of Dermatology on an outpatient basis, for atopic dermatitis. On admission, the patient bad erythematosquamous, moderately infiltrated plaque-like lesions, some of 68 tbem reacbing tbe size of a palm. Tbey consisted of keratotic papules witb borny plugs involving extensor, side of tbe arms, cubital fossae, tbigbs, popliteal fossae and knees (Figs. 1,2). Tbere were individual keratotic foci over the dorsal aspect of tbe , bands. The distal parts of tbe nails were tbickened and split. Tbe scalp sbowed diffuse scaling. Tiny pink, scaly papules were noted on the laterni borders of the eyebrows. All visible mucous membranes were normal. Erytbrocyte sedimentation rate, blood screen, serum electrolytes, bilirubin, transaminases, alkaline pho- sphatase, serum amylase, lipid count, urea and creatinine levels were witbin normal limits. Faecal smears for parasites and stool cultures for Crypto- sporidium, fungi, Mycobacterium tuberculosis were negative. No tubercle bacilli were isolated from the urine and sputum. From tbe tbroat smear normal flora was recovered. Tbe serologic test for sypbilis was negative, wbile the tests for rbeumatoid artbritis were positive (AST 1:240 IU/ml, Latex 240 IU/ml, Waaler-Rose test 1:512 IU/ml; otber tests were negative). The serologic test for toxoplasmosis was negative. Tota! serum IgE levels were elevated to 210 IU/ml. Specific IgE to Phleum pratense and Dermatophagoides pteronyssinus were found positive. Cbest X-rays and ultrasound of tbe abdomen were normal. Roentgenologic examination of tbe right elbow and rigbt sboulder sbowed degenerative lesions of tbe joints. Histopatbology of a plaque on tbe rigbt upper arm revealed a predominantly atrophic epidermis with intermittent areas of normal tbickness. An area of acantbosis and a large invagination of tbe epidermis, filled out with abundant byperkeratotic masses, were noticed (Fig. 3). A narrow streak of parakeratosis was seen at tbe upper border. Tbere were areas of liquefaction degeneration of tbe basal cells. In tbe upper dermis, a dense licbenoid infiltrate was noticed, composed of lympbocytes, bistiocytes and a few eosinopbils (Fig. 4). The Kongo red stain failed to reveal amyloid. Electron microscopic examination showed cytolytic cbanges of keratinocytes of tbe basal layer and lower spinous layer (Figs. 5,6). Tbere was an intercellular oedema. Numerous lympbocytes, mono- cytes, macrophages and some basopbilic, eosinopbilic and neutrophilic granulocytes, otherwise forming dense infiltrates in tbe dermal papillary layer, were found in tbose areas (Fig. 5). Tbere was a focal thickening of tbe granular layer of tbe epidermis witb kera- tinocytes containing thin tonofilament bundles and acta dennatovenerologica A.P A. Vol 4, 95, No 2 Keratosis lichenoides chronica Fig. l. Distribution of skin lesions. sparse, rounded keratohyalin granules. The thickened horny layer showed no abnormalities, apart from focal parakeratosis. Other epidermal Fig. 2. Keratotic papules and plaque-like lesions on the left upper extremity. acta dermatovenerologica A .P A. Vol 4, 95, No 2 Fig. 3. Massive hyperkeratosis with a narrow streak of parakeratosis. Areas of thinned epidermis. Under the epidermis, dense band-like dermal cellular infiltrate. HE, 25x and dermal elements had normal ultrastructure. Direct immunofluorescence studies demonstrated band- like deposits of fibrin, IgG and C3 at the dermo-epidermal junction and globular IgM deposits in the upper dermis. Prior to admission to this Department, the patient had been treated by PUV A on severa! occasions, yet he noticed no improvement. Fig. 4. Higher magnification of features in Fig. 3 showing the dense lichenoid infiltrate, consisting of lymphocytes and histiocytes. Signs of initial liquefaction degeneration in the acanthotic epidermis. HE, 63x Treatment with nonspecific topical ointments, local steroids 0 and orally administered antihistamines from October 19.85 to November 1992 produced no clinical improvement either. Also, the patient was therapeutically unresponsive Keratosis lichenoides chronica Fig. 5. Cytolytic changes in a keratinocyte of the lower spinous layer. Electron micrograph, 13000x to local selective phototherapy (long-wave UV-B and UV-A) received in 1985. Another course of 30 irradiations given in 1992 caused temporary dete- rioration of the dermatosis. After the histopathologic diagnosis of KLC was established, the patient was placed on a 2-month course of oral etretinate 30 mg/day. The dose was then increased to 40 mg/day (0,5 mg/kg BW) for 2 months and thereafter reduced to 30 mg daily for another 2 months. Later, the patient was placed on etretinate 20 mg/day and Re-PUV A therapy; two hours before each irradiation he received Oxsoralen 40 mg. The patient was given 29 irradiations on the PUVA 4000 (Waldmann) apparatus. The total dosage received was 119 J/cm2• The therapy produced flattening of papules and plaques, and arrested desquamation. Some areas of papules with horny plugs on the upper limbs had disappeared. At the end of therapy the patient began to experience occasional itching and burning. After the disconti- nuation of the therapy, sparse fresh papules re- appeared. During the treatment, the test for lipids became slightly pathologic. Other side effects included loss of hair, and dryness of the mouth and buccal mucosa. The therapy had no effect on nail lesions. DISCUSSION The term KLC summarizes the leading clinical characteristics of the disease (5), but it does not clarify its etiology (6) nor does it imply that KLC is an independent disease entity (3,4,6,7,9). In the literature there is a disagreement concerning the factors causing KLC. These seem to include antimalarial and antituberculous agents (3,8) - taken 70 Fig. 6. Keratinocyte of the granular layer with thin tonofilament bundles and sparse pounded grains of keratohyalin. Electron micrograph, 13000x also by our patient - tetanus antiserum (9) , skin damage and coverage with skin grafts (6). KLC may be associated with other diseases, such as atopic dermatitis (5,10), allergic rhinitis (3), pulmonary tuberculosis (5) , hepatitis A (3), chronic lymphatic leukemia (2), neurologic disorders (11), clinically manifest toxoplasmosis, or positive serologic tests for toxoplasmosis (12-14). Chronic asymptomatic course of KLC without spontaneous remissions, with the onset in adult age was characteristic of our case. The disease only rarely occurs in children (10,15,16). It usually lasts over 10 years. A 15-year history of KLC, as seen in our patient, has been reported by some other authors (17,18). As documented in the literature, KLC is only rarely associated with skin itching (9,19). Our patient experienced it after topical application of 0,1 % tretinoin and on completion of Re-PUVA therapy. Arthralgia was partly due to degenerative changes. He also had positive serologic tests for rheumatoid arthritis, which constitutes a symptom only rarely described in connection with KLC (5,18). The course of the illness, the distribution and quality of skin lesions are similar to the description by Margolis et al. (17) and by other authors (2-8, 10, 12, 1 7-25). Histopathological findings, including acanthosis, parakeratosis and subepidermal lichenoid lymphocytic and histiocytic infiltrate agree with most observations found in the literature (5,6,8-10,16,20,24). Another feature reported by some investigator~ was a perivascular infiltrate in the upper dermis (3,13,17). Infiltrate composed of eosinophils bas also been found in some previous studies (3,20). Liquefaction acta dermatovenerologica A.P A. Vol 4, 95, No 2 Keratosis lichenoides chronica degeneration of the basal layer has been widely reported in the literature (5-7,10,14,17,18,22), and so have been hyperkeratotic plugs in the invaginations of the epidermis (5,7-9, 11,21,24). Electron microscopic results resemble those in Iichen ruber planus (26,27). Like Dupperat et al. (23), we found no viral particles. As previously observed by some other investigators, the results ot direct immunofluorescence microscopy of skin lesions partially resembled the findings characteristic of lichen ruber planus (1,6,7,9,16,24). The treatment modalities described so far do not afford complete cure of the disease. Topical application of steroids produced no evidence of benefit, regardless of the concentration of the glucocorticoid used; other authors reported a poor or no response to treatment with local mercury preparations, iodine compounds, salicylic acid preparations and numerous systemic agents , including vitamins A and B, chloroquine sulfate, antibiotics, gold salts, griseofulvin, methotrexate, zync sulphate, glucocorticoids, sulpho- namydes , dapsone and levamisole (3,14,17,18,24,25). In the literature there are no reports on successful treatment with selective phototherapy, while some authors described fair improvement after PUV A therapy (10,25) ; in our patient selective phototherapy and PUV A failed to produce clinical improvement. On the other hand, systemically administered etretinate afforded the expected improvement (14,21,22,25), yet it was only partial, temporary and dependent on the dose given. Fairly good response to Re-PUV A therapy was reported by Duchet et al. (12). In our case, we observed better results of this treatment modality than those yielded by administration of etretinate alone. Some keratotic plugs disappeared and the flattening of skin plaques was noticed; however, sparse fresh papules reappeared one month after the completion of the therapy. In view of the established pathogenesis and the predominance of T4 lymphocytes in the cellular infiltrations of KLC (12,21 ), we think it reasonable to introduce cyclosporin A in the future treatment of KLC. It helps regulate the T4 (helper) / T8 (suppressor) ratio, and depresses the function of T4 lymphocytes (28,29). Cyclosporin A is also recommended in the management of other chronic infiltrative dermatoses (30,31,32). Our patient refused it because of the possible renal side effects. Acknowledgment: We wish to thank Dr. Marija Berčič for her valuable suggestions and help with histopathological findings . REFERENCES l. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Keratosis lichenoides chronica. In: Dermatology, 3rd edn., Vol. 1, Berlin: Springer-Verlag, 1991: 529. 2. Skorupka M, Kuhn A, Mahrle G. Keratosis lichenoides chronica. Hautarzt 1992; 43: 97-9. 3. Braun-Falco, Bieber T, Heider L. Keratosis lichenoides chronica: Krankheitsvariante oder Krank- heitsentitat? Hautarzt 1989; 40: 614-22. 4. Baran R, Panizzon R, Goldberg L. The nails in keratosis lichenoides chronica. Arch Dermatol 1984; 120: 1471-4. 5. Kint A, Coucke C, De Weert J. Keratosis liche- noides chronica. Dermatologica 1976; 153: 290-7. 6. Kersey P, Ive FA. Keratosis lichenoides chronica is synonymous with lichen planus. Ciin Exp Dermatol 1992; 7: 49-54. 7. Chapman RS. Lichen verrucosus et reticularis. Dermatologica 1971; 142: 363-73. acta dermatovenerologica A.P.A. Vol 4, 95, No 2 8. Bureau Y, Barriere H, Litoux P, Bureau B. Dermatose papulohyperkeratosique, en stries. Cas pour diagnostic. Bul soc franc Derm Syph 1970; 77: 347-9. 9. Pino] Aguade J, De Asper J, Ferrando J. Lichenoid Tri-Keratosis (Kaposi-Bureau-Barriere-Grupper). Der- matologica 1974; 148: 179-88. 10. Lange PG. Keratosis lichenoides chronica. Arch Dermatol 1981; 117: 105-8. 11. Chandon JP, Gamby T, Arland J et al. Keratose lichenoide striee et pseudo-ainhum associe a un tableau neurologique complexe. Ann Derm Venereol (Paris) 1977; 104: 45-9. 12. Duschet P, Schwarz T, Gschnait F. Keratosis lichenoides chronica. Hautarzt 1987, 38: 678-82. 13. Menter MA, Morrison JGL. Lichen verrucosus et reticularis of Kaposi (porokeratosis striata · of Nekam): a manifestation of acquired adult toxo- plasmosis. Brit J Dermatol 1976; 94: 645-54. 71 Keratosis lichenoides chronica 14. Schnitzler L, Bouteiller G, Bechetoille A, Verret JL. Keratose lichenoide chronique avec atteinte muqueuse synechiante severe. Etude evolutive sur 18 ans. Therapeutique par le retinoide aromatique. Ann Dermatol Venereol (Paris) 1981; 108: 371-9. 15. Barriere H, Litoux P, Bureau B et al.: Keratose Lichenoide striee. Forme congenitale. Ann Derm Venereol (Paris) 1977; 104: 767-9. 16. Raynaud F . Keratose lichenoide striee infantile. Dermatologica 1983; 167: 180-1. 17. Margolis MH, Cooper GA, Johnson SAM. Keratosis lichenoides chronica. Arch Dermatol 1972; 105: 739-44. 18. Petrozzi JW. Keratosis lichenoides chronica. Arch Dermatol 1976; 112: 709-11. 19. Degos R, Civatte J, Jourdain C, Dassonville M. Keratose lichenoide avec atteinte muqueuse et infiltrat a eosinophiles pharyngo-larynge. Ann Dermatol Venereol (Paris) 1977; 104: 54-5. 20. Degos R, Labouche F, Civatte J et al. Keratose lichenoide striee. Ann dermatol Syphiligr 1974; 101: 391-2. 21. Fraitag S, Oberlin P, Bourgault I et al. Keratose lichenoide striee. Ann Dermatol Venereol (Paris) 1989; 116: 900-2. 22. Balus L, Fuga GC. Keratose lichenoide chronique. Ann Dermatol Venereol (Paris) 1982; 104: 739-40. 23. Duperat B, Carton FX, Denoeux JP te al. Keratose lichenoide striee. Ann Dermatol Venereol (Paris) 1977, 104: 546-6. 24. Mac Donald DM, Wiliams DI. Lichen verrucosus et reticularis of Kaposi (porokeratosis striata of Nekam). Case reports. Brit J Dermatol 1974; 91(suppl. 10): 39-40. 25. Ryatt KS, Greenwood R, Coterill JA. Keratosis lichenoides chronica. Brit J Dermatol 1982; 106: 223-5. 26. Ebner H. Untersuchungen liber die cellulare Zusammensetzung des Lichen ruber planus-Infiltrates. Arch Derm Forsch 1973; 247: 309-18. 27. Ebner H, Erlach E, Gebhart W. Untersuchungen liber die Blasenbildung beim Lichen ruber planus. Arch Derm Forsch 1973; 247: 193-205. 28. Kahan BD. Cyclosporine A: A selective anti-T celi agent. Ciin hematol 1982; 11: 743-61. 29. Kahan BD. Drug therapy - cyclosporine. N Engl J Med 1989; 321: 1725-38. 30. Eisen D, Vorrhee JJ. Effect of topical cyclosporine rinse on oral lichen planus. N Engl Med 1991; 325: 435. 31. Mozzanica N, Cattaneo A, Legori A et al. Immunohistologic evaluation on the effect of cyclo- sporine treatment on lichen planus immune infiltrate. J Am Acad Dermatol 1991; 24: 550-4. 32. Munro CS, Higgins EM, Marks JM et al. Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effect on allergic reactions. Br J Dermatol 1991; 124: 43-8. AUTHORS' ADDRESSES Anica Smrkolj MD, PhD, dermatologist, Department of Dermatology, Medica! Center, Zaloška 2, 61000 Ljubljana, Slovenija 72 Ranka Popovič MD, MSc, dermatologist, same address Tomaž Lunder MD, MSc, dermatologist, same address acta dennatovenerologica A.P A. Vol 4, 95, No 2